@lisapham

Journalist and writer. Opinions are my own.

 London, England
Joined June 2008
  • Tweets608
  • Following291
  • Followers1.1K
2Media
Finland's Neste has attracted more attention from short sellers than any other oil stock in Europe’s benchmark equity index, a sign of how high the stakes are when the company faces investors this week bloomberg.com/news/articles/… @markets @lisapham

One of Europe’s Most Shorted Oil Stocks Faces a Day of Reckoning

No other oil stock in Europe’s benchmark equity index has attracted as much attention from short sellers as Neste Oyj. It’s a sign of how high the stakes are when the company faces investors this...

bloomberg.com
1
289
Hearing aid makers have become one of the stock market’s less likely artificial intelligence plays bloomberg.com/news/articles/… via @technology @lisapham

Swiss Hearing-Aid Maker Transforms Into Unlikely AI Stock Winner

Hearing-aid makers have become one of the stock market’s less likely artificial intelligence plays.

bloomberg.com
2
1
308
Novo Nordisk has fallen behind Eli Lilly this year in the race to be the big stock market winner from obesity drugs. Analysts expect the Danish company to start catching up bloomberg.com/news/articles/… via @markets @lisapham

Novo Nordisk Shares Seen Outpacing Lilly’s After Summer Stumble

Novo Nordisk A/S has fallen behind Eli Lilly & Co. this year in the race to be the big stock market winner from obesity drugs. Analysts expect the Danish company to start catching up.

bloomberg.com
3
3
1,220
Amid the frenzy surrounding weight-loss medicines, one biotech company is rewarding investors by focusing on a much more low-profile area of drug development bloomberg.com/news/articles/… via @markets @lisapham
1
250
With the outlook for travel weakening as consumers pull back on spending, short sellers are betting that Wizz Air will fare worse than its European peers bloomberg.com/news/articles/… via @markets @BbgGulyas @kwakutwt @lisapham
3
2
376
Superbugs death toll could swell by millions over the coming years bloomberg.com/news/articles/… via @lisapham
1
1
1
437
Positive results in the earliest stages of development have driven about $93 billion in market value gains this year for obesity-drug makers, according to Bloomberg calculations bloomberg.com/news/articles/… via @business @naomikresge @lisapham

Two Dozen Patients Are Worth Billions in Pharma’s Hottest Market

The 25 people in Roche Holding AG’s obesity pill study would barely be enough to field both sides of a soccer match. Yet their weight loss added $16.8 billion to the Swiss drugmaker’s market value in...

bloomberg.com
1
1
339
To deliver what could be one of the UK’s biggest-ever IPOs, Shein will need to win over politicians and investors. Critics point to ESG concerns, including allegations the firm’s products are linked to forced labor bloomberg.com/news/articles/… via @markets @lisapham @WilliamShaw546

Shein Steers Tough Course in Pursuit of Blockbuster London IPO

London bankers have waited more than two years for initial public offerings to bounce back. When news that fast-fashion upstart Shein could list first emerged at a potential £50 billion ($64 billion)...

bloomberg.com
1
2
327
Lisa Pham retweeted
Thyagu
@Thyagu29 May 2024
If anyone even remembers this one! It took years to get London-Shanghai connect going and much-lesser time for it to fall off the radar. bloomberg.com/news/articles/…… via @markets @lisapham @PhilSerafino
1
1
248
Lisa Pham retweeted
Thyagu
@Thyagu9 May 2024
After the 2% IPO story - here's a follow up from @lisapham & @marketsjoe on what difference the government’s proposal for a tax-free savings account would mean to the UK in terms of flows bloomberg.com/news/articles/… via @markets
2
2
350
Lisa Pham retweeted
Thyagu
@Thyagu8 May 2024
London is missing out on a rebound in Europe’s IPO market - Just 2% share of European IPOs, a new low for the market!! bloomberg.com/news/articles/… via @markets @marketsjoe @lisapham
1
1
223
Pre-close calls with analysts have been a tradition in markets for years. Some investors say the practice needs to change. bloomberg.com/news/articles/… via @business

Stock Traders Push Back on 'Unfair' Pre-Close Calls

Company pre-close calls with analysts are coming under scrutiny.

bloomberg.com
1
434
Jeremy Hunt is likely to turn to retail investors in an attempt to save the UK market. But one version of UK ISA winning support may cost taxpayers thousands of pounds - stripping out tax relief on overseas firms. With @lisapham and @marketsjoe bloomberg.com/news/articles/…

Jeremy Hunt Turns to Retail Investors to Save the UK Market

Jeremy Hunt wants UK retail investors to help revive the fortune of the country’s ailing stock market, which has been beset by underperformance, outflows and an exodus of companies.

bloomberg.com
6
2
5
5,833
NEW: What is the Ozempic & Zepboud effect on the financial markets? Drugmaker Eli Lilly ($LLY) has exceeded Tesla ($TSLA) in market value, and some say the stock should be added to the Magnificent 7 index that also includes Nvidia ($NVDA) @lisapham reports bloomberg.com/news/articles/…
2
5
9
20,957
Lisa Pham retweeted
Lisa Pham@lisapham29 Mar 2023
Here’s me using a necklace to explain how short selling works…
Bloomberg Originals
@bbgoriginals29 Mar 2023
Short-seller Hindenburg made a splash when it took on India's richest man. Now, it's targeting Jack Dorsey's Block. @lisapham tells you what you need to know about short selling trib.al/icwV14i
8
2
30
4,595
#Shares in #ozempic maker #Novo are unlikely to repeat a banner year, with competition rising and a valuation that some see as stretched. With @jonasekblom @lisapham: bloomberg.com/news/articles/…

Ozempic Maker’s Obesity-Fueled Gains Seen Slowing After Banner Year

A frenzy around obesity drugs made Novo Nordisk A/S Europe’s biggest stock-market success story of 2023. Repeating the trick won’t be so easy.

bloomberg.com
1
2
301
Lisa Pham retweeted
Bloomberg
@business17 Dec 2023
Novo Nordisk will struggle to repeat this year's gains as the weight-loss stock frenzy subsides trib.al/CcQb6SE

Ozempic Maker’s Obesity-Fueled Gains Seen Slowing After Banner Year

A frenzy around obesity drugs made Novo Nordisk A/S Europe’s biggest stock-market success story of 2023. Repeating the trick won’t be so easy.

bloomberg.com
5
4
1
12
34,265
Lisa Pham retweeted
Bloomberg
@business7 Nov 2023
Long Covid patients might benefit by learning how to keep their brain waves in a comfort zone. trib.al/Mjisqpj

Changing Brain Waves to Help Recover From Long Covid Crashes

Hi, it’s Lisa in London, where I’ve been thinking about whether it’s possible to manage my long Covid condition by changing my brain waves. But before we get to that...

bloomberg.com
3
2
4
26,222
Ever wanted an easy way to understand how the put option deals beloved by Mike Ashley’s Frasers work? Then listen to the excellent @lisapham explain the ins and outs of it all at her local garden centre. (Reason #1305 to love a garden centre too!)
Bloomberg
@business2 Nov 2023
What are equity derivatives? @lisapham explains the concept using potted plants trib.al/qjc9keV
1
2
2
1,314
Little wonder that Simon Wolfson is buying up other brands. He and Mike Ashley own an increasing amount of the high street. Great piece on that by @lisapham & @KatieLinsell Why a Lord and a Billionaire Are Battling for the Future of UK Retail 👇LINK bloomberg.com/news/articles/…

Why a Lord and a Billionaire Are Battling for the Future of UK Retail

The Next CEO Simon Wolfson and the founder of Frasers, Mike Ashley, are pursuing different strategies in a contest to consolidate Britain’s high street.

bloomberg.com
2
1
320
Load more